Management of Henoch-Schonlein Purpura with Gastrointestinal Manifestations in Children

Authors

  • Rizki Luthfia Wardhani Pediatric Department, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia
  • Siti Ariffatus Saroh Pediatric Department, Dr. Sayidiman Magetan Hospital, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia

DOI:

https://doi.org/10.24853/mmj.4.1.15-24

Keywords:

children, HSP, purpura, vasculitis

Abstract

Henoch-Schonlein Purpura (HSP) is systemic vasculitis in children, hallmark by inflammatory infiltration of polymonuclear leukocytes in small blood vessels, followed by IgA1 immune deposits. HSP prevalence is approximately 3-27 cases per 100,000 children. The inflammatory process in HSP causes an ischemia and hemorrhagic process characterized by non-thrombocytopenia purpura, arthralgia, gastrointestinal problems, and kidney impairment. This process is called leukocytoclastic vasculitis. A 10-year-old boy came to ER of Dr. Sayidiman Magetan Hospital presenting with diffuse abdominal pain and purpura skin lesions in body. The complaint started with a red rash on both legs, then progressively extended to both hands, thighs, and buttocks, and continued with severe abdominal discomfort, nausea, dizziness, fever, and the patient also experienced a brownish-black stool. The patient was diagnosed with Henoch-Schonlein purpura with gastrointestinal manifestations based on medical examination. The patient stayed for six days at the hospital, and the condition improved.

Author Biographies

Rizki Luthfia Wardhani, Pediatric Department, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia

Pediatric Department, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia

Siti Ariffatus Saroh, Pediatric Department, Dr. Sayidiman Magetan Hospital, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia

Pediatric Department, Dr. Sayidiman Magetan Hospital, Faculty of Medicine, Muhammadiyah Surakarta University, Surakarta, Indonesia

References

Abbas A., Lichtman A., Pillai S. Cellular and Molecular Immunology (6th ed.). Philadelphia: Saunders Elsevier; 2007.

Breda L, Carbone I, Casciato I, Gentile C, Grasso EA, di Donato G, et al. Epidemiological and clinical aspects of immunoglobulin A vasculitis in childhood: a retrospective cohort study. Ital J Pediatr. 2021 Dec;47(1):237.

Sivaraman V, Fels E, Stacy P. Nelson Textbook of Pediatrics (21st ed.). Philadelphia: PA: Elsevier; 2019.

Oni L, Sampath S. Childhood IgA Vasculitis (Henoch Schonlein Purpura)—Advances and Knowledge Gaps. Front Pediatr [Internet]. 2019 Jun 27;7:1–10.

Hochberg MC, Gravallese EM, Silman A, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology (7th Ed.). Philadelphia: Elsevier; 2019.

Jauhola O. Henoch-Schönlein purpura in children. University of Oulu; 2012.

Sonawane V, Kotrashetti V, Bainade K, Nair S, Yewale S. Henoch-Schonlein purpura in child: a case report and review of the literature. Int J Contemp Pediatr. 2020 Dec 23;8:193.

Tendean S, Siregar SP. Purpura Henoch-Schönlein. Sari Pediatr. 2016;7(1):45.

Matondang C, Roma J. Purpura Henoch Schonlein. In: Buku Ajar Alergi-Imunologi Anak Ed2. Jakarta: Balai Penerbit IDAI; 2008. p. 373–7.

Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990 Aug;33(8):1114–21.

Retnaningtyas LP. Henoch-Schonlein Purpura ( HSP ). 2019;1(1):19–26.

Demircioğlu Kılıç B. Determination of Risk Factors in Children Diagnosed With Henoch-Schönlein Purpura. Arch Rheumatol [Internet]. 2018 Dec 6;33(4):395–401.

Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schonlein Purpura in children: clinical analysis of 120 cases. Afr Health Sci. 2013 Mar;13(1):94–9.

Fairudz Shiba A, Natasha D, Mulyadi F, Kurniati I. Henoch Schonlein Purpura with Predominant Gatrointestinal Manifestation. J. 2019;6:442.

Chen J-Y, Mao J-H. Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2015 Feb;11(1):29–34.

Prameswari R, Indramaya D, Sandhika W. Imunopatogenesis Leukositoklastik Vaskulitis pada Henoch-Schonlein Purpura (The Immunopathogenesis of Leukocytoclastic Vasculitis in Henoch-Schonlein Purpura). Berk Ilmu Kesehat Kulit dan Kelamin J. 2012;24(3):185–91.

Kurnia B. Henoch-Schonlein Purpura in Children: The Role of Corticosteroids. Open Access Maced J Med Sci [Internet]. 2019 Jun 15;7(11):1812–4.

Yang Y-H, Yu H-H, Chiang B-L. The diagnosis and classification of Henoch–Schönlein purpura: An updated review. Autoimmun Rev [Internet]. 2014 Apr;13(4–5):355–8.

Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet (London, England). 2007 Mar;369(9566):976–8.

Kawasaki Y, Suzuki H. Henoch-Schonlein Nephritis. In: Comprehensive pediatric nephrology. Philadelphia: Mosby Elsevier; 2008.

Ozen S. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis [Internet]. 2005 Nov 3;65(7):936–41.

Robinowitz L. Henoch-Schönlein purpura. In: Textbook of Pediatric-Dermatology. Oxford: Blackwell Science; 2000.

Wardhana AW, Satria CD, Hapsara S. Nephritis Predictive Factors in Children with Henoch-Schonlein Purpura. Sari Pediatr. 2017;18(3):209.

Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of Corticosteroid on Henoch-Schönlein Purpura: A Systematic Review. Pediatrics [Internet]. 2007 Nov 1;120(5):1079–87.

Downloads

Published

2023-03-17